CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies
Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn—a potential game-changer for the companies developing CRISPR-based therapies.
In the studies, published in Nature Medicine, scientists found that cells whose genomes are successfully edited by CRISPR-Cas9 have the potential to seed tumors inside a patient. That could make some CRISPR’d cells ticking time bombs, according to researchers from Sweden’s Karolinska Institute and, separately, Novartis.
|CRISPR meets the law of unintended consequences||1256||Nolondil||18-Jun-18 19:54|
|Re: CRISPR meets the law of unintended consequences||208||D-Archer||20-Jun-18 13:48|
|Re: CRISPR meets the law of unintended consequences||157||strontium3bood||01-Aug-18 14:07|
|Re: CRISPR meets the law of unintended consequences||161||Lost_In_Place||01-Aug-18 15:49|
|Re: CRISPR meets the law of unintended consequences||303||Lost_In_Place||04-Aug-18 02:58|